Terazosin hydrochloride dihydrate is a quinazoline derivative and a competitive and orally active alpha1-adrenoceptor antagonist. Terazosin hydrochloride dihydrate works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride dihydrate has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment[1][2][3].
Molekulargewicht:
459.92
Reinheit:
99.92
CAS Nummer:
[70024-40-7]
Formel:
C19H30ClN5O6
Target-Kategorie:
Adrenergic Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten